🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as yttrium Y 90 ibritumomab tiuxetan...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2003-12
Trial ID
NCT00073957
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Institut Bergonie
Start Date
2007-01-23
Trial ID
NCT00467142
Treatments Being Tested
RATIONALE: Monoclonal antibodies can locate cancer cells and either kill th...
Status
Unknown
Location
University of California Davis Cancer Center
Start Date
2001-02
Trial ID
NCT00008021
H. pylori positive patient volunteers that passed the selection criteria ar...
Status
Completed
Location
108 Military Central Hospital
Start Date
2013-06
Trial ID
NCT02721355
Treatments Being Tested
The primary objective of Part 1 (Single Ascending Dose) is to assess the sa...
Status
Completed
Location
Linear Clinical Research - Harry Perkins Research Institute
Start Date
2020-09-18
Trial ID
NCT04567810
Treatments Being Tested
The purpose of this trial is to describe antibody persistence and response ...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01239043
This phase II trial studies how well giving combination chemotherapy and be...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2011-03
Trial ID
NCT01320683
The aim of the study is to test \[90\]Y-ibritumomab tiuxetan, a radioactive...
Status
Completed
Location
Multiple Locations
Start Date
2001-08
Trial ID
NCT00185393
Treatments Being Tested
Single arm- subject treated with Tegoprubart and everolimus. The purpose o...
Status
Recruiting
Location
Diabetes Research Institute, University of Miami
Start Date
2027-04-29
Trial ID
NCT07592000
Treatments Being Tested
Recently, the availability of R has substantially changed therapeutic appro...
Status
Completed
Location
Irst - Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori - Sede Di Meldola (Fc)
Start Date
2012-07
Trial ID
NCT02063685